Stay updated on Foster® pMDI vs Symbicort® Turbohaler in COPD Patient Clinical Trial

Sign up to get notified when there's something new on the Foster® pMDI vs Symbicort® Turbohaler in COPD Patient Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Foster® pMDI vs Symbicort® Turbohaler in COPD Patient Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.4.3, replacing the previous Revision: v3.4.2.
    Difference
    0.0%
    Check dated 2026-03-07T08:57:41.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    The page shows a minor revision update from v3.4.1 to v3.4.2, with no changes to the study content or results. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-13T17:36:59.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    Revision updated from v3.4.0 to v3.4.1. No substantive updates to study details or workflow are observed.
    Difference
    0.0%
    Check dated 2026-02-06T12:15:59.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    UI and metadata updates include a glossary toggle (Show/Hide glossary) and new status labels (Results Submitted, Last Update Submitted that Met QC Criteria) along with added No FEAR Act Data and Revision: v3.4.0. The previous labels 'No Results Posted', 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4' have been removed or replaced.
    Difference
    0.3%
    Check dated 2026-01-23T10:10:48.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.3.4, replacing Revision: v3.3.3.
    Difference
    0.0%
    Check dated 2026-01-16T05:19:06.000Z thumbnail image
  8. Check
    92 days ago
    Change Detected
    Summary
    A comprehensive Locations section has been added, listing trial sites by country and city (e.g., Anhui, Beijing, Chongqing, etc.), and the previous location listings have been removed in Revision: v3.3.3.
    Difference
    2%
    Check dated 2025-12-18T04:56:52.000Z thumbnail image

Stay in the know with updates to Foster® pMDI vs Symbicort® Turbohaler in COPD Patient Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Foster® pMDI vs Symbicort® Turbohaler in COPD Patient Clinical Trial page.